Accretion Nutraveda Shares Debut at ₹191, Surge 48% Over IPO Price

The Accretion Nutraveda shares made a strong and impressive debut on the Indian stock market on February 4, 2026, attracting attention from investors and analysts alike. The healthcare and nutraceutical company debuted on the BSE SME platform at ₹191 per share, marking a 48 percent premium over its IPO issue price of ₹129. This performance highlights strong investor appetite for smaller and growth‑oriented firms even amid broader market uncertainties, and underscores how stock market activity can offer potential gains from well‑timed IPO investments.